Home
About
FAQ
History (6)
Inflammatory myofibroblastic tumor associated with renal cell carcinoma.
The von Hippel-Lindau gene: turning discovery into therapy.
TRAIL and interferon-alpha act synergistically to induce renal cell carcinoma apoptosis.
Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival?
Recent advances in targeted therapy for renal cell carcinoma.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Recent advances in targeted therapy for renal cell carcinoma.
Clark PE. Recent advances in targeted therapy for renal cell carcinoma. Curr Opin Urol. 2007 Sep; 17(5):331-6.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Carcinoma, Renal Cell
Humans
Kidney Neoplasms
Neoplasm Staging
Protein Kinase Inhibitors
Protein Kinases
Protein-Tyrosine Kinases
Signal Transduction
Treatment Outcome
Vascular Endothelial Growth Factor A
authors with profiles
Peter E. Clark MD